Misba Beerahee

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

Anthony Cahn, Simon T. Hodgson, Robert C. Wilson et al. · BMC Pharmacology and Toxicology · 2013 · 52 citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +19

Inhibition of capsaicin‐driven nasal hyper‐reactivity by <scp>SB</scp>‐705498, a <scp>TRPV</scp>1 antagonist

Carlijn Holland, Cornelis M. van Drunen, Jane Denyer et al. · British Journal of Clinical Pharmacology · 2013 · 31 citations · Full text

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough

Valerie J. Ludbrook, Kate Hanrott, James L. Kreindler et al. · ERJ Open Research · 2021 · 31 citations · Full text

Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

Navin Goyal, Misba Beerahee, Chris Kalberg et al. · Clinical Pharmacokinetics · 2014 · 30 citations

Inhaled Umeclidinium, Advanced Lung Disease, Pharmacology +5

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

Alison Church, Misba Beerahee, Jean Brooks et al. · BMC Pulmonary Medicine · 2014 · 29 citations · Full text